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Rotaviruses are the major pathogens that cause life-threatening diarrhea in young children and animals. We
inserted a simian rotavirus SAll gene 6 cDNA into the genome of the baculovirus Autographa californica
nuclear polyhedrosis virus adjacent to the strong polyhedrin promoter. The major capsid antigen (VP6) was
expressed in high yields (20 to 150 eug/106 cells) when Spodopterafrugiperda cells were infected with baculovirus
recombinants containing SAll gene 6 inserts. Reactivity with monospecific polyclonal and monoclonal
antibodies suggested that VP6, expressed intraceliularly or found in the media, maintained native antigenic
determinants. VP6 purified from the media from infected cells also possessed a native oligomeric structure, was
immunogenic in guinea pigs, and was able to spontaneously assemble into morphologic subunits. Antisera from
immunized guinea pigs failed to neutralize virus in plaque reduction assays, but detected homologous and
heterologous rotavirus strains when tested by immunofluorescence, immunoprecipitation, and enzyme-linked
immunosorbent assays.
The importance of rotaviruses as etiologic agents of infan-
tile diarrhea in humans and animals is now clearly estab-
lished (10, 14). The recognition that the rotaviruses are the
major cause of life-threatening diarrheal disease and of
significant morbidity in the young has focused efforts on
disease prevention and control against these viruses.
Studies on rotavirus gene structure and function are
expected to help these efforts. For example, the cloning and
subsequent expression of individual protein products are
helping elucidate the function of each protein in virus
structure, replication, and assembly. Analysis of the anti-
genic, functional, and molecular properties of expressed
gene products, alone or in conjunction with other viral
proteins, will also allow intrinsic properties of each gene
product to be determined. In addition, humoral and cell-
mediated immune response(s) to specific viral proteins will
be more easily and directly dissected with the availability of
high levels of individual proteins. Finally, the availability of
large amounts of immunogenic structural proteins will facil-
itate vaccine testing and the production of inexpensive
diagnostic tests.
The genome of rotaviruses consists of 11 segments of
double-stranded RNA. The genome RNA is enclosed within
a double-layered protein capsid that is made up of the
structural proteins VP1 to VP9 (8). Each genome segment
encodes at least one protein (8, 17), and knowledge of the
properties of the structural proteins is increasing. The outer
capsid proteins (VP3 and the glycoprotein VP7) function as
the viral hemagglutinin (H antigen, VP3) and neutralization
(N antigen, VP7) antigens. VP3 also induces neutralizing
antibodies. The major capsid protein that comprises >80%
of the protein mass of the particle is located on the inner
capsid and contains the subgroup antigen (S antigen, VP6)
(8). The presence of VP6 on virus particles has been asso-
ciated with viral RNA polymerase activity (4), and VP6 may
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bind to RNA genome segments or transcripts or interact with
other viral proteins during replication and assembly (8). VP6
has recently been reported to possess an oligomeric (possi-
bly trimeric) conformation (12), and it is also the major
protein detected in diagnostic enzyme-linked immunosor-
bent assays (ELISA) (3). Neutralizing and protective anti-
bodies are produced to the outer capsid H and N antigens
(21), but information on whether other structural proteins
(VP1, 2, 6, and 9) play a role in inducing protection from
infection is less clear.
We report the successful production of the major capsid
antigen (VP6) of the simian rotavirus SAl1 in insect cells,
using the baculovirus Autographa californica nuclear
polyhedrosis virus (AcNPV) as an expression vector. VP6
was produced efficiently, and the majority of the protein was
found in the media from infected cells. Immunologic and
biochemical analysis indicated that the protein possessed
both native antigenic determinants and an oligomeric con-
formation. The availability of large amounts of VP6 will help
determine intrinsic biochemical and functional properties of
this protein in the rotavirus replication process, including
viral morphogenesis.
MATERIALS AND METHODS
Cells and virus. The simian rotavirus SAl1 was grown in
cultures of MA104 cells as previously described (9). The
baculovirus A. californica (AcNPV) and the recombinant
virus pAc461/SA11-6 were used to infect Spodoptera
frugiperda (IPLB-SF21-AE) cells at a multiplicity of infec-
tion of 10 PFU per cell. S. frugiperda cells were grown and
maintained on Hink's medium containing 10% fetal bovine
serum (FBS) (26).
Construction and selection of baculovirus recombinants
containing SAll gene 6 cDNA inserts. SAll gene 6 was
originally cloned in the PstI site of pBR322 (10). The
resulting clone, pSA11-6, was digested with Ahalll and
HpaII and subcloned into the SmaI site of the baculovirus
transfer vector pAc461. Plasmid pAc461 was derived from
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FIG. 1. Construction of the baculovirus expression vector for
rotavirus SAl gene 6 synthesis. The full-length SA1l gene 6 cDNA,
pSA11-6, was digested with AhaIIl and HpaII and filled in with the
Klenow fragment. Purified insert DNA was cloned into the SmaI
site of pAc461 by blunt-end ligation. The resultant vector,
pAc461/SA11-6, contains the SAl gene 6-coding region fused to the
polyhedrin leader sequence. The TATA region, the CAP site for
transcription initiation, and the ATG initiation codon of the chimeric
gene are boxed. Symbols: O, polyhedrin promoter region; m,
polyhedrin-coding sequences; _, SAl gene 6 sequences; -,
pBR sequences; -, AcNPV sequences. The baculovirus pAc461
vector was derived from pAc311 by cleavage with BamHI and KpnI,
digestion with Bal 31 nuclease, and ligation of a SmaI linker. This
vector has a deletion between -7 and +670 within the polyhedrin
gene.
pAc311 (26) by cleavage with BamHI and KpnI, digestion
with Bal 31 nuclease, treatment with DNA polymerase I
(Klenow fragment) to produce blunt ends, ligation of a SmaI
(GCCCGGGC) linker, cleavage with SmaI, and religation.
Plasmid pAc461 has a deletion between positions -7 and
+670 in the baculovirus polyhedrin gene. After transfection
into Escherichia coli, plasmids in recombinant ampicillin-
resistant colonies were screened by restriction enzyme anal-
ysis for inserts in the correct transcriptional orientation. One
of these, designated pAc461/SA11-6, is missing the first
seven nucleotides of the 5' end of SAl 1 gene 6 and has about
70 extra base pairs of tails that were added at the 3' end
during the original cloning into pBR322 (Fig. 1). Transfer of
SAl gene 6 cDNA from this vector to the AcNPV genome
DNA was achieved by cotransfection of S. frugiperda cells
with wild-type AcNPV DNA, using the calcium phosphate
precipitation procedure as previously described (26). Briefly,
the AcNPV DNA (1 p.g) was mixed with 2 ,ug of pAc461/
SA11-6 DNA, brought to 950 ,u with HEBS/CT (0.137 M
NaCl, 6 mM D-glucose, 5 mM KCl, 0.7 mM
Na2HPO4 7H20, 20 mM HEPES [N-2-hydroxyethyl-
piperazine-N'-2-ethanesulfonic acid], 15 ,ug of sonicated calf
thymus DNA per ml, pH 7.1) and vortexed. While the
mixture was being slowly vortexed, 50 RI of 2.5 M CaCl2 was
added, and a precipitate was allowed to form at room
temperature for 30 min. The pecipitated DNA was added to
2 ml of Hink's medium supplemented with 10% FBS in a
25-cm2 flask seeded with 2.5 x 106 S. frugiperda cells.
Following incubation at 27°C for 4 h, the medium was
removed, the monolayer was washed with fresh Hink's
medium containing 10% FBS, and, after addition of 5 ml of
Hink's medium supplemented with 10% FBS, the flask was
incubated at 27°C. The cells were observed with an inverted
microscope for signs of infection, and, at an advanced stage
of infection (day 5), extracellular virus was harvested and
plaqued on monolayers of S. frugiperda cells. Recombi-
nants, in which the polyhedrin gene had been replaced by the
polyhedrin-SA11-6 transfer vector DNA by homologous
recombination, were selected by identifying occlusion-
negative plaques with an inverted phase microscope (26).
Virus in occlusion-negative plaques was plaque purified
three times and used to propagate virus stocks. Three
recombinant virus stocks, designated pAc461/SA11-6.1,
pAc461/SA11-6.2, and pAc461/SA11-6.3, were used for fur-
ther analyses.
Radiolabeling of proteins synthesized in infected S.
frugiperda cells. S. frugiperda cells infected with
recombinant/SA11-6 or with wild-type AcNPV were radio-
labeled at different times postinfection with 15 ,uCi of
[35S]methionine per ml in methionine-free Hink's medium
supplemented with 10% FBS. The cells and media were
harvested at 42 h postinfection, and the cells were pelleted at
1,400 x g at 4°C for 5 min. The cell-free supernatant was
removed and saved for testing, and the cell pellet was
suspended in RIPA buffer (0.15 M NaCl, 0.01 M Tris
hydrochloride [pH 7.2], 1% aprotinin, 1% sodium deoxycho-
late, 1% Triton X-100, 0.1% sodium dodecyl sulfate). Pro-
teins were immunoprecipitated from these samples as previ-
ously described (5). Antisera used for immunoprecipitation
were a polyclonal guinea pig anti-SAl serum (gp aSA11)
that reacts with SAl structural proteins VP2, 3, 6, and 7 (7)
or ascites fluids from mice injected with hybridoma cells
(produced by Harry Greenberg and kindly provided by Tom
Flewett, World Health Organization Collaborating Centre
for Rotaviruses, Birmingham, U.K.) that secrete monoclo-
nal antibodies to VP6 subgroup 1(255/60, aSGI) or subgroup
II (631/9, oaSGII) or to a common determinant on VP6 (631/7,
acommon) (13). The specificity of these monoclonal antibod-
ies was demonstrated by ELISA and by immunoprecipita-
tion assays with human and animal rotavirus strains (13; M.
K. Estes, S. E. Crawford, and M. E. Penaranda, unpub-
lished data). In some cases the immunoreactivity of the
expressed protein was also analyzed by immunoblots (J. W.
Burns and M. K. Estes, manuscript in preparation).
Partial purification of the expressed rotavirus VP6. Recom-
binant-infected S. frugiperda cells were labeled 28 h postin-
fection with [35S]methionine (30 ,uCi/ml, 1,200 Ci/mmol;
Amersham Corp., Arlington Heights, Ill.) in Hink's medium
lacking FBS. The cells and media were harvested separately
between 90 and 106 h postinfection by scraping cells into the
media and pelleting the cells by centrifugation at 1,000 rpm
for 20 min at 4°C in a Damon IEC centrifuge. In some cases,
VP6 was purified from the media by centrifuging clarified
(100,000 x g for 30 min) media containing VP6 on a 5 to 20%
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continuous sucrose gradient for 23 h at 100,000 x g. Frac-
tions containing the expressed VP6 that lacked contaminat-
ing bovine serum albumin were pooled, dialyzed against 10
mM Tris hydrochloride (pH 7.5), and used either directly or
after lyophilization.
In some experiments, wild-type AcNPV and recombinant
expressed proteins were prepared by using the same infec-
tion conditions and harvesting procedure, but were not
purified further. In this case, medium from infected cells was
collected, dialyzed against 10 mM Tris hydrochloride (pH
7.5), and used directly or lyophilized. Concentrations of VP6
were approximated by comparing the amounts of VP6 to
quantitative marker proteins after electrophoresis on 12%
polyacrylamide gels and staining with silver nitrate or
Coomassie blue or by a quantitative ELISA.
Affinity purification of expressed VP6. Protein A-Sepharose
CL-4B affinity columns (Pharmacia, Inc., Piscataway, N.J.)
were prepared by cross-linking subgroup I monoclonal su-
pernatant to the gel, using dimethylpimelimidate dihydro-
chloride (25). Unlinked antibody was removed by washing
with 0.1 M borate buffer (pH 8.3). Supernatants from S.
frugiperda cells infected with pAc461/SA11-6.1 were mixed
with the immunomatrix, shaken at room temperature, and
centrifuged at 1,500 rpm for 1 min in a Damon IEC centri-
fuge. The immunomatrix gel was then suspended in borate
buffer and poured into a disposable Econocolumn (Bio-Rad
Laboratories, Richmond, Calif.). The column was washed
sequentially with 50 ml each of buffer A (0.5 M NaCl, 0.05 M
Tris hydrochloride [pH 8.2], 0.5% Nonidet P-40), buffer B(0.15 M NaCl, 0.05 M Tris hydrochloride [pH 8.2], 0.5%
Nonidet P-40, 0.1% sodium dodecyl sulfate), and buffer C
(0.15 M NaCl, 0.5% sodium deoxycholate), with borate
buffer washes between each. After a final wash with borate
buffer, VP6 was eluted from the gel with 0.1 M glycine-HCl(pH 2.5) into tubes containing 2 M Tris base to neutralize the
acid. The eluted VP6 was analyzed by electrophoresis on
12% polyacrylamide gels and was used as a standard in
ELISA to quantitate the kinetics and levels of expression of
VP6.
Production of antiserum to expressed VP6. Guinea pigs(Elm Hill Breeding Farms, Chelmsford, Mass.) shown to
lack rotavirus antibodies were used for the production of
antiserum to expressed VP6 protein. Each guinea pig was
inoculated intramuscularly twice at 3-week intervals as
previously described (9). The antigens used were partially
purified expressed VP6 or proteins concentrated from the
supernatant from S. frugiperda cells infected with either
AcNPV or pAc461/SA11-6. The guinea pigs were bled 1
week after the second injection of antigen, and the serum
samples were tested for the presence of antibodies by
immunofluorescence, immunoprecipitation, ELISA, and im-
mune electron microscopy assays as previously described
(5, 9, 20).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Protein products were analyzed by polyacrylamide slab gel
electrophoresis, using a modification of the method of
Laemmli with 12% separating and 4% stacking gels as
previously described (5). Before electrophoresis, unless oth-
erwise stated, samples were dissociated by boiling for 3 min
in sample buffer containing 1% sodium dodecyl sulfate, 10%
2-mercaptoethanol, 0.5 M urea, 0.05 M Tris hydrochloride(pH 6.8), 10% glycerol, and 0.0025% phenol red. Radiola-
beled proteins were monitored on gels following
fluorography as previously described (17).
Electron microscopy. Supernatant from S. frugiperda cells
infected with pAc461/SA11-6.1 which had been dialyzed into
AcNPV
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FIG. 2. Kinetics of VP6 synthesis in infected S. frugiperda cells.
The proteins synthesized in mock (M)-, wild-type baculovirus
(AcNPV)-, or baculovirus recombinant (SAl1 gene [G] 6.2)-infected
S. frugiperda cells were labeled with [35S]methionine (30 ,Ci/ml) at
the indicated times (in hours). The proteins in cells harvested 2 h
later were then analyzed in 12% sodium dodecyl sulfate-
polyacrylamide gels. Polyhedrin and SAil VP6 are indicated by
arrowheads in the left- and right-hand panels, respectively.
10 mM Tris hydrochloride, pH 7.5, was diluted with an equal
volume of 0.3 M NaCl-20 mM EDTA, pH 6.0, and kept at
4°C for several weeks. Samples for electron microscopy
were adsorbed onto carbon-collodion-coated grids and neg-
atively stained with 2% aqueous uranyl acetate. Reagents for
immunogold labeling were prepared by direct coupling of
oaSGI and monoclonal antibody against the nonstructural
glycoprotein (aNS29) to 7-nm colloidal gold particles as
described previously (6). After adsorption of the sample to
the grid, labeling was accomplished by floating the grids on
20-,ul drops of the appropriate antibody-gold complex for 30
min at room temperature. Grids were then washed in dis-
tilled water and stained with uranyl acetate.
RESULTS
Expression of SAll VP6 in S. frugiperda cells. Three
baculovirus recombinants (6.1 to 6.3) containing an SAl1
gene 6 cDNA insert were initially identified and tested for
their ability to produce SAl1 VP6 after infection of S.
frugiperda cells. The [35S]methionine-containing polypep-
tides in cells infected with AcNPV or SAl1 gene 6 recom-
binant are shown in Fig. 2. A new band of the expected
molecular weight (41,000) was seen in recombinant-infected
cells, while the polyhedrin protein was only seen in AcNPV-
infected cells. Radiolabeled VP6 was initially detected at 22
h postinfection, and its synthesis was still detectable at 105 h
postinfection (see below).
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FIG. 3. Immunoreactivity of SAl VP6 expressed in S.
frugiperda cells. [35S]methionine-labeled proteins synthesized in
wild-type- or SAl gene 6 recombinant (SAl 6.1 or SAl 6.2)-
infected S. frugiperda cells. AcNPV polyhedron (0) and SAll VP6
(4) are highlighted. The immunoreactivity of these proteins with
antiserum to SAl particles (aSA11) or with monoclonal antibodies
to epitopes present (aSGI, COM) or absent (aSGII) on SAl1 VP6 or
with no serum (-) is shown. The left-hand panel shows reactivity of
cell-associated VP6, while the panel on the right shows reactivity
with VP6 from cells (C) or from the medium supernatant (S) from
cells infected with two different gene 6 recombinants. The weaker
reactivity shown between VP6 from the supernatant and SAl
serum (compared with the SGI reactivity) was not reproducible;
other experiments showed similar strong positive reactivity with all
three antisera and VP6 in the supernatant.
Immunoreactivity and localization of expressed VP6. The
41,000-molecular-weight protein (41K band) was identified
as authentic VP6 by positive immunoreactivity with poly-
clonal antisera prepared to SAl virus and with monoclonal
antibodies to two epitopes (common and subgroup I) on the
SAl VP6 (Fig. 3). Specificity of these reactions was shown
by a lack of reactivity of the subgroup II antibody with the
SAl 41K protein and by finding that no proteins in AcNPV-
infected cells reacted with any of these sera. Similar results
were obtained with all three recombinants.
We also examined the cellular localization and levels of
expression of VP6. VP6 was observed in the cytoplasm of
recombinant-infected cells by immunofluorescence (data not
shown), and it could be immunoprecipitated from both
clarified supernatants and cell-associated proteins (Fig. 3).
The amount of protein being synthesized was quantitated by
analysis of dilutions of immunoprecipitated VP6 (data not
shown) and by ELISA (Fig. 4) standardized with VP6
purified to radiochemical and biochemical homogeneity from
an immunomatrix column. Results from such analyses esti-
mated that cell-associated VP6 was produced in infected
cells in amounts of 20 to 150 ,ug from a density of 106 cells per
ml. The ELISA results also showed that immunoreactive
VP6 could be detected as early as 8 h postinfection and that
the amount of VP6 found in the medium increased with time.
Yields of VP6 in clarified media were sufficient to allow
purification for further biochemical and immunologic stud-
ies. Yields of VP6 were greatest when cells were grown in
complete media containing 10% FBS.
Conformational properties of expressed VP6. Gorziglia et
al. (12) have presented evidence that VP6 removed from
purified bovine rotaviruses or analyzed in infected cells
behaves as an oligomeric (possibly trimeric) protein. This
experiment offered an independent way to examine whether
expressed SAl VP6 possessed conformational properties
similar to authentic VP6. Figure 5 shows that the profile of
[35S]methionine-labeled proteins in purified single-shelled
virus after electrophoresis in SDS-polyacrylamide gels was
different depending on whether or not the virus was heated
before the gels were loaded. In the presence of heating,
characteristic bands representing VP1 (125K), VP2 (94K),
and VP6 (41K) were seen. In the absence of heating, the VP6
band disappeared and a new band migrating above VP1 was
observed. These control data have extended the observa-
tions of Gorziglia and co-workers to SAl (another rotavirus
strain). Similar analyses with baculovirus-expressed VP6
(partially purified on sucrose gradients) and with immunoaf-
finity-purified VP6 showed that these proteins also formed
oligomers (Fig. 5). In the absence of reducing agents (2-
mercaptoethanol), an additional band that also migrated as
an oligomer was observed. Monomeric and oligomeric forms
of expressed VP6 were also seen by using immunoblots.
These analyses confirmed that the expressed VP6 possessed
a native conformation and showed that oligomer formation
must be an intrinsic property of VP6. The expressed VP6
also assembled spontaneously into tubules after several
weeks at 4°C (Fig. 6). These tubules showed a hexagonal
array of subunits that resembled those which have been
observed in stool samples from children and animals infected
with rotavirus. The hexagonal subunit pattern on the tubules
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FIG. 4. Detection of VP6 expression by ELISA. ELISA results
showing amounts of VP6 detected by ELISA in media (0) or in
SAl1-infected S. frugiperda cells (-) at the indicated times postin-
fection. The amounts of VP6 at each time-point were quantitated by
direct comparison of the optical density (OD) readings of SAl1
6.1-infected cell samples with the OD values on a standard curve of
a known amount of affinity-purified VP6. Background OD values
(0.001 to 0.016) from mock and wild-type AcNPV-infected cells
were subtracted. The range of amounts of VP6 detected in different
infections is shown.
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FIG. 5. Comparison of conformation of expressed and authentic
VP6. The polypeptides in single-shelled (SS) SAl particles or in
baculovirus-expressed VP6 were separated on 12% polyacrylamide
gels after heating at either 100°C for 2 min or 37°C for 30 min in
sample buffer in the presence (+) or absence (-) of 1B-
mercaptoethanol (BME). The gels were processed by fluorography
and autoradiography to detect radiolabeled proteins, or the sepa-
rated proteins were electrophoretically transferred to nitrocellulose
and then detected by using the SGI monoclonal antibody.
also closely resembled that seen on the inner capsid of
several rotavirus strains. Immunogold labeling of these
tubules with the SGI monoclonal antibody (Fig. 6B) and not
with a monoclonal antibody to the nonstructural glycopro-
tein (Fig. 6C) confirmed that the tubules were composed of
VP6. These results demonstrate that assembly into
capsomerelike structures is another intrinsic property of
VP6.
Characterization of antisera produced to expressed VP6.
Antisera were produced in guinea pigs to concentrated
wild-type AcNPV-infected S. frugiperda cell proteins, to
concentrated SA11-6.1-infected S. frugiperda cell proteins,
and to VP6 partially purified from the media of infected S.
frugiperda cells by sucrose gradient centrifugation. The
ability of each antiserum to recognize VP6 was tested by
immunoprecipitation (Fig. 7). All preimmune sera and the
antiserum to the AcNPV-infected S. frugiperda proteins
failed to react with any cellular or viral proteins in the
SAil-infected MA104 cell lysates, while antisera to the
unpurified and to the partially purified VP6 reacted specifi-
cally with VP6. These antisera could also be used for virus
detection. The anti-VP6 sera detected rotavirus strains rep-
resenting each known human serotype and subgroup in both
immunofluorescence tests and ELISA (data not shown). The
anti-VP6 sera did not neutralize SAll infectivity when tested
in plaque reduction neutralization assays with 50 PFU of
virus.
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FIG. 7. Characterization of guinea pig antiserum produced to
expressed VP6. [35S]methionine-labeled polypeptides in SAi1-
infected MA104 cells (lane 1) were immunoprecipitated with guinea
pig antiserum made to concentrated proteins from wild-type
baculovirus (AcNPV)-infected S. frugiperda cells (lane 5); VP6
purified from recombinant-infected S. frugiperda cells (lane 6);
concentrated (but unpurified) proteins from SA11-6.1-infected S.
frugiperda cells (lane 7); or purified double-shelled SAl (lane 8).
Lane 9 shows VP6 immunoprecipitated with monoclonal antibody to
the SGI epitope on VP6. Preimmune serum from all animals showed
no reactivity with any proteins from these lysates (lanes 2 to 4).
Viral proteins VP2, VP3, VP5, VP6, and VP7 that react with
antiserum to double-shelled virus are seen in lane 8; VP6 is
highlighted with an arrow. Lanes 2 to 9 show analyses performed
with undiluted or a 1:10 dilution of the indicated serum.
DISCUSSION
The production of viral proteins in high yields from
expression vector systems offers new ways to study viral
protein function and to develop diagnostic tests and vac-
cines. We have evaluated the antigenic and molecular prop-
erties of the simian rotavirus SAll major capsid protein
VP6, produced by using a baculovirus expression system.
Several properties of the expressed VP6 are noteworthy.
First, although VP6 is not a glycoprotein and is not found in
the media from SAll-infected cells, it was present in the
media from the baculovirus recombinant-infected cells. The
current study did not determine whether VP6 was actively
secreted or was released only as a result of cell lysis, but its
presence in the media greatly facilitated the purification of
VP6. Other nonglycosylated proteins, P-galactosidase and
chloramphenicol transferase, have also been found in the
media after production with the same baculovirus expression
vector (G. E. Smith and M. D. Summers, unpublished
observation).
Second, VP6 was expressed in its native conformation.
Reactivity with available monoclonal antibodies suggested
that native immunoreactive determinants were conserved.
Further evidence of a native conformation was provided by
the demonstration that the expressed (and purified) protein
was an oligomer, the reported structure of VP6 in virus-
infected cells or in virus particles (12). This observation
strongly suggests that oligomer formation is an intrinsic
property of this protein. However, our data differ from those
of Gorziglia et al. (12), as we observed that the formation of
multiple oligomeric forms is associated with disulfide bonds.
Although seen with radiolabeled VP6, this property of VP6
was observed more clearly by using a sensitive protein-
blotting procedure to detect the oligomers.
Electron microscopic analysis revealed that further as-
sembly of the trimeric VP6 molecules into morphologic
subunits resembling those on single-capsid particles oc-
curred spontaneously, although slowly. These subunits have
also been seen following selective removal of VP6 from the
inner capsid of virus particles (4). The present data indicate
that interactions with other viral proteins or with preformed
subviral structures are not required for subunit formation,
although such interactions may accelerate the process. The
availability of large amounts of purified capsid proteins will
now facilitate dissection of the factors that control particle
morphogenesis and may ultimately allow self-assembly of
virus capsids, as recently accomplished with expressed VP1
of polyomavirus (24). The characteristics of VP6 shown here
also extend the known properties of proteins synthesized
with the baculovirus expression system. The native confor-
mation of SAl VP6 reported here is consistent with other
studies that show the use and advantages of this system to
produce eucaryotic proteins (16, 18, 19, 26, 28).
The possible uses of expressed VP6 to improve current
diagnostic tests for rotaviruses are of considerable interest.
Antiserum made to unpurified or partially purified VP6
detected common antigenic determinants shared by all group
A rotaviruses. An unexpected property of this antiserum
(made even to unpurified protein) was its lack of reactivity
with mammalian cell proteins. Further evaluation will deter-
mine whether this serum will significantly improve sensitiv-
ity or specificity of diagnostic tests. However, since VP6 is
the major protein detected in commercial diagnostic tests
based on either monoclonal or polyclonal antisera, the future
production of such reagents by using baculovirus-expressed
VP6 (or other rotavirus proteins) might be cost-effective due
to the high yields and the ability to produce this protein from
infected cells grown in spinner cultures. Expression of the
proteins of other rotavirus strains, particularly noncul-
tivatable strains such as some human group A or the
non-group A rotaviruses, could be particularly beneficial.
Future efforts will evaluate the use of expressed VP6 as a
vaccine, using animal models that can measure passive and
active protection against virus challenge. Antisera to ex-
pressed VP6 produced in the current study did not neutralize
virus in plaque reduction assays. This result agrees with
previous reports that monoclonal antibodies to VP6 do not
neutralize virus in vitro (13, 22, 29), but it contrasts with
other reports that antiserum to gel-purified VP6 possesses
low titers of neutralizing antibodies (2, 15, 23). The inability
of the expressed VP6 to induce neutralizing antibodies,
however, does not rule out a possible role for this protein in
inducing protection from infection or disease, as our under-
standing of the immunologic and nonimmunologic mecha-
nisms that are critical to induce protection from rotavirus
infection and disease remains incomplete (8). VP6 might be
important in stimulating cell-mediated immune responses
FIG. 6. Assembly of expressed VP6 into structures with capsomerelike morphology. (A) Tubular structures seen in samples of expressed
VP6. These structures show hexagonal subunit arrangements typical of the rotavirus inner capsid. (B) VP6 structures labeled with aSGI-
gold complex. (C) VP6 structure reacted with aNS29-gold complex. No specific binding occurred. Magnification bars equal 100 nm.
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that induce reported heterotypic immunity in a fashion
similar to that of the proteins of influenza virus (1, 30, 31).
Baculovirus-expressed VP6 may also be a useful component
of future subunit vaccines containing additional expressed
outer capsid (VP3 and VP7) proteins.
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